Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG on November 21 and set a price target of CHF106.00. The company’s shares ......

Cineverse ( ($CNVS) ) has issued an announcement. On November 20, 2025, Cineverse Corp. amended its 2017 Equity Incentive Plan to increase the numb......

Morgan Stanley analyst Thibault Boutherin maintained a Buy rating on Novartis AG yesterday. The company’s shares closed today at CHF100.42. Bouther......

Bernstein analyst Florent Cespedes maintained a Buy rating on Novartis AG yesterday and set a price target of CHF108.00. Cespedes covers the Health......

Alliance Global Partners analyst Brian Kinstlinger maintained a Buy rating on Cineverse on November 18 and set a price target of $6.00. The company......

Olema Pharmaceuticals stock rallied on Tuesday alongside an update from rival drugmaker Roche. ...

Berenberg Bank analyst Luisa Hector maintained a Hold rating on Novartis AG today and set a price target of CHF92.00. According to TipRanks, Hector......

In a report released on November 14, David Evans from Kepler Capital maintained a Buy rating on Novartis AG, with a price target of CHF106.00. The ......

Cineverse Corp. (($CNVS)) has held its Q2 earnings call. Read on for the main highlights of the call. Cineverse Corp.’s recent earnings call painte......

In a report released today, Sumant Kulkarni from Canaccord Genuity maintained a Buy rating on Annovis Bio, with a price target of $17.00. According......